Press release
Rising Cancer Incidence To Drive Market Growth: A Key Factor Shaping the Future of the Neulasta Market in 2025
Neulasta
The neulasta market's growth is propelled by the increasing occurrence of cancer. Cancer, described as a collection of diseases with abnormal cell growth, can metastasize to other sections of the body. Various factors like aging demographics, unhealthy living habits, and environmental elements contribute to the rising cancer cases. Pegfilgrastim biosimilars like neulasta are essential for cancer patients undergoing chemotherapy as they aid in preventing chemotherapy-induced neutropenia. They do this by stimulating the production of white blood cells and diminishing the likelihood of infections. For example, data from the Australian Institute of Health and Welfare in August 2024 suggests that by 2034, Australia is expected to record about 209,000 new cancer diagnoses, marking a substantial increase from the projected 169,000 cases for 2024. Furthermore, cancer is predicted to be responsible for roughly 3 out of every ten deaths in the country by 2024. Consequently, the escalating number of cancer cases will stimulate the neulasta market growth.
Get Your Neulasta Market Report Here:
https://www.thebusinessresearchcompany.com/report/neulasta-global-market-report
What is the future CAGR of the neulasta market, and how will it impact industry expansion?
In recent times, the market size of Neulasta has seen a HCAGR of XX. It is projected to expand from $XX million in 2024 to an impressive $XX million in 2025, witnessing a compound annual growth rate (CAGR) of XX%. The substantial growth during the historic period can be linked to factors such as increased occurrence of chemotherapy-induced neutropenia, the rise in global cancer cases, enhanced awareness about the dangers of neutropenia during cancer therapy, supportive government funding for biologics, and the early utilization of biologics in advanced regions.
Expectations for the neulasta market size's potential growth focus on XX% compound annual growth rate (FCAGR) over the forthcoming years. This surge is projected to realize a market value of $XX million by the end of 2029. Elements contributing to this prospective growth during the forecast timeline include the proliferation of biosimilars in developing markets, heightened demand for economically viable cancer-supportive care, escalating global healthcare expenditure, increased biosimilar approvals from regulatory bodies, and better public knowledge about biosimilar options. Key trends shaping the forecast period encompass the production of prefilled syringes for more effortless drug administration, advancements in drug delivery methods such as on-body injectors, digital platform utilization for patient education, the application of AI in biologics R&D and efficient supply chain management, along with strategic collaborations between biologic and biosimilar corporations.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20159&type=smp
What are the most significant trends transforming the neulasta market today?
A significant trend in the Neulasta market revolves around the development of novel drug delivery technologies like prefilled autoinjectors, as a strategy for gaining industry competitiveness. These are self-injecting devices preloaded with medication, intended for easy, convenient self-administration by patients. For instance, in March 2023, US based biopharmaceutical firm, Coherus Biosciences, declared that the FDA had sanctioned a one-dose, prefilled autoinjector form of its biosimilar pegfilgrastim, Udenyca (pegfilgrastim-cbqv), used in treating and preventing febrile neutropenia, a common side effect of chemotherapy. This autoinjector lets patients receive pegfilgrastim a day post chemotherapy, minimizing febrile neutropenia risk. The device is designed with a push-on-skin activation feature for consistent, immediate delivery of a complete pegfilgrastim dose.
Which key market segments comprise the neulasta market and drive its revenue growth?
The neulasta market covered in this report is segmented -
1) By Indication: Chemotherapy-Induced Neutropenia, Bone Marrow Transplantation, Other Indications
2) By Formulation: Injectable Solution, Pre-Filled Syringes Or Pens
3) By Distribution Channel: Hospitals, Oncology Clinics, Specialty Pharmacies, Home Healthcare Services
4) By End User Patients: Adult Patients, Pediatric Patients
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20159
What regions are at the forefront of neulasta market expansion?
North America was the largest region in the neulasta market in 2024. The regions covered in the neulasta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Who are the leading players fueling growth in the neulasta market?
Major companies operating in the neulasta market include Amgen Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20159&type=smp
What Is Covered In The Neulasta Global Market Report?
•Market Size Forecast: Examine the neulasta market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the neulasta market for a structured understanding.
•Key Players Overview: Analyze major players in the neulasta market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the neulasta market.
•Segment Contributions: Evaluate how different segments drive overall growth in the neulasta market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the neulasta market.
•Industry Challenges: Identify potential risks and obstacles affecting the neulasta market.
•Competitive Landscape: Review strategic developments in the neulasta market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Cancer Incidence To Drive Market Growth: A Key Factor Shaping the Future of the Neulasta Market in 2025 here
News-ID: 3937799 • Views: …
More Releases from The Business Research Company
Key Trends Reshaping the Agricultural Biotechnology Market: Innovative Biotechno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Agricultural Biotechnology Market Size Growth Forecast: What to Expect by 2025?
In recent times, the agricultural biotechnology market has witnessed considerable growth. It is anticipated to expand from $44.82 billion in 2024 to $49.18 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 9.7%. This significant increase…
Health-Conscious Trends Propel Growth In Sorghum Seed Market: Transformative For …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Sorghum Seed Industry Market Size Be by 2025?
Over recent years, the sorghum seed market has experienced a significant uptick in growth. The market is projected to escalate from a value of $2.06 billion in 2024 to $2.18 billion in 2025, advancing at a compound annual…
Steady Expansion Forecast for Meat Market, Projected to Reach $1599.32 Billion b …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Meat Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The expansion of the meat market has been robust in the last few years. The market which is projected to be at $1133.29 billion in 2024 is expected to escalate to $1217.95 billion in 2025 with…
Grain Farming Industry Outlook 2025-2029: Market Set to Cross $1633.78 Billion M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Grain Farming Market Size By 2025?
In the past few years, the size of the grain farming market has significantly expanded. It is projected to rise from $1139.2 billion in 2024 to $1226.32 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%.…
More Releases for Neulasta
Neulasta Market Growth Driven by Oncology Care Advances and Biosimilar Entry, 20 …
The qualitative latest Research report (2025-2032) on the Neulasta Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/8171
Focused on growth and future…
Neulasta Market: An Analysis of Size, Shares, Business Growth, and Upcoming Tren …
The Neulasta Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Neulasta industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial…
Rising Cancer Incidence To Drive Market Growth: A Key Driver Powering Neulasta M …
The Neulasta Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Neulasta Market Size and Its Estimated Growth Rate?
In recent years, the market size of neulasta has experienced a XX (HCAGR). Its growth is projected to climb from $XX million in 2024…
Global Neulasta (Pegfilgrastim) And Biosimilar Market Size by Application, Type, …
USA, New Jersey- According to Market Research Intellect, the global Neulasta (Pegfilgrastim) And Biosimilar market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The market for pegfilgrastim and biosimilars is expanding significantly, mostly due to the rising use of chemotherapy-based cancer treatments. By promoting the formation…
Key Driver Reshaping the Neulasta Market in 2025: Rising Cancer Incidence To Dri …
How Is the Neulasta Market Projected to Grow, and What Is Its Market Size?
In recent times, there's been an $XX expansion in the Neulasta market size. Starting with a worth of $XX million in 2024, it's projected to reach $XX million in 2025, progressing at a compound annual growth rate (CAGR) of $XX%. The evolution during this historic period is associated with the increasing instances of chemotherapy-induced neutropenia, rising cases…
Neulasta Pegfilgrastim and Biosimilar Market Trends, Size, Segments, Key Growth …
This report segments the Neulasta Pegfilgrastim and Biosimilar Market comprehensively. The regional market sizes, concerning products by type, by application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Neulasta Pegfilgrastim and Biosimilar Market Size was estimated at 10.59 (USD Billion)…
